FDA Drug Application (018891) for CATAPRES-TTS-2 by BOEHRINGER INGELHEIM

Back to FDA Applications sponsored by BOEHRINGER INGELHEIM

Application Number018891
Product Number002
FormFILM, EXTENDED RELEASE;TRANSDERMAL
Dosage0.2MG/24HR
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameCATAPRES-TTS-2
Active IngredientCLONIDINE

Active IngredientCount
List of drugs with Active Ingredient CLONIDINE4


Back to FDA Applications sponsored by BOEHRINGER INGELHEIM